Evorin pharma

Evorin pharma http://evorin.com/ Professional treatment with the most scientifically advanced solutions

Evorin pharma is a leading health services and innovation company on a mission to continuously generate groundbreaking ideas in the name of Health and beauty. We have years of experience in developing innovative products and unique treatment methods and we promise to continue this tradition of excellence. Building a unique portfolio of Health and beauty and related brands, striving to surpass competitors in quality, innovation, and value, and elevating Evorin's image to become the world's most trusted Pharmaceutical and Cosme-ceutical company.

AI MRI empowers increased throughput and exceptional image quality at PotsdamAfter acquiring Philips SmartSpeed, Dr. Tob...
04/10/2025

AI MRI empowers increased throughput and exceptional image quality at Potsdam

After acquiring Philips SmartSpeed, Dr. Tobias Schr?ter was astonished at the great potential of this AI MRI technology. It sets the stage for rapid, high quality MRI exams in his practice. He points out that across all anatomies, he discovers that shorter scan times and exceptional detail means faster, more confident diagnoses. Patient throughput has improved by about 20 percent.

At-a-glance:
Using SmartSpeed with AI showed Dr. Tobias Schr?ter that sharp, high-resolution images in short times means faster, more confident diagnoses.
It allowed the practice to improve its patient throughput by about 20 percent.
Motion artifacts no longer play a major role as patients’ stay shorter in the magnet and SmartSpeed reduces motion artifacts better than before.
Use of 3D imaging for all joints helps visualize very small structures. MPRs of tendons, ligaments, cartilage with this high-resolution help see the extent of possible injuries.

Making a difference with fast, powerful technology
Dr. Tobias Schr?ter, MD, has been a radiologist since 2000. After running a 24/7 radiology practice for 16 years, he took over MRT-Praxis Potsdam, specializing in MRI diagnostics. “After the takeover, I completely redesigned the premises and exchanged the older MRI machine for a 1.5T Philips Ingenia Ambition S with sealed magnet.”

Recently, the MRI Practice in Potsdam acquired AI-based Philips SmartSpeed of which Dr. Schr?ter has found that it makes a significant difference. “We had already been using Compressed SENSE from Philips to accelerate our cartesian scans and increase throughput. SmartSpeed now allows us to further reduce scan times and artificial intelligence (AI) makes the image quality even better compared to images we acquired using Compressed SENSE.”

Dr. Schr?ter now uses SmartSpeed for 2D and 3D sequences in all anatomies. “I am astonished at the great potential of SmartSpeed, especially because 3D imaging in MSK is becoming feasible now. I can get very good image quality in very short scan time.” He also uses SmartSpeed for patients that cannot hold still, without worrying about needing re-scans. And it can also be used for patients with implants.

“Besides the fast scanning, we now have the advantage of fast image reconstruction, so that we can already look at images while the scanning is still ongoing.”

Higher patient throughput
MRT-Praxis Potsdam mostly focuses on neuro imaging and musculoskeletal examinations. They also perform prostate examinations, and occasionally some abdominal MRI.

“Philips SmartSpeed really helps us scan more patients per day,” Dr. Schr?ter says. “We achieve higher throughput and better productivity without compromising on image quality. We used to scan 32 to 35 patients per day, but now with SmartSpeed we can perform significantly more examinations in less time. We went from 160 to 170 exams per week before SmartSpeed to up to 200 per week, or about 40 patients per day.

“The short MRI scan times that we realize with SmartSpeed also provide better comfort for all our patients. Not everyone is comfortable lying in the scanner. Even normal, healthy individuals often cannot lie still for that long, which may lead to motion artifacts. So, being able to image faster is an obvious benefit. Our average examination time is now about 10 minutes. Only a few of our exams need more than 20 minutes.”

Faster scans, faster diagnoses [1], high productivity
“Thanks to SmartSpeed, we are able to perform examinations extremely quickly. We can carry out most examinations in under ten minutes. Our MRI exam of the knee only takes six minutes. The shorter time makes it easier for patients to lay still, which helps prevent motion artifacts.

Then, because the computing capacity is so large, we have the images immediately available on the large screen. Higher resolution is very valuable. From the high-resolution 3D sequences, excellent multiplanar reconstruction can be obtained. This makes it easier and faster for us to diagnose and create reports. And while the patient is still lying in the magnet, we can already view the images and make a diagnosis. When the patient comes out, I can immediately ask whether what I see corresponds to the symptoms.”

Dr. Schr?ter also highlights their step forward in MRI of the prostate. “In prostate exams we have saved almost 50 percent of time. We used to need about 35 minutes for an MRI exam of the prostate and now we can do it in just 18 minutes with a significantly higher resolution and higher image quality.”

According to Dr. Schr?ter the advances that come with SmartSpeed enable them to more frequently use metal artifact suppression sequences, such as O-MAR, for imaging joints with prostheses. This sequence can now be acquired in the relatively short time of three minutes and Dr. Schr?ter observes significant progress in recognizing anatomy in the vicinity of the prostheses.

SmartSpeed brought options for motion-free imaging, so motion artifacts no longer play a major role like before. Dr. Schr?ter says the team sees fewer repeat scans when using SmartSpeed, “Firstly, because patients’ time in the magnet is shorter, and secondly because SmartSpeed MotionFree reduces motion artifacts better than before.”

How SmartSpeed helps
According to Dr. Schr?ter MRI is a powerful imaging modality, but for producing images with high resolution and excellent detail, a long scan time is often required. In addition, motion artifacts can be a problem, as remaining motionless throughout the exam is difficult for many patients.

“Now, with SmartSpeed, we can achieve better results – high image resolution and razor-sharp images – in the shortest possible time. That is an advantage both for the patient and for us: the patient gets out of the scanner faster and diagnosing and reporting is easier for us.”

“I can use SmartSpeed on patients with implants and for patients that cannot hold still, without worrying about re-scans due to motion. I am astonished by the great potential of SmartSpeed. I can get very good image quality in very short scan time, and 3D imaging in MSK is now feasible for us.”

A leap in MSK imaging thanks to SmartSpeed
Previously, the practice wasn’t able to use 3D imaging on all joints, because the time required was too long, and on some joints it was simply not possible to achieve a good quality image, Dr. Schr?ter says. “Now, with SmartSpeed we consistently use 3D imaging for all joints and can thus discover the smallest changes, for example in the cartilage. And that, of course, helps us in making a detailed diagnosis.”

Dr. Schr?ter says their MSK images show high contrast and extremely high quality. He mentions the menisci as an example. “We use a 3D proton density weighted fatsat sequence, thickness is 0.3 mm and scan time 3 minutes. The MPRs show an unbelievable resolution. Very small tears and even fraying of the tip of the meniscus become visible, which is normally only possible in arthroscopic surgery.

When imaging the small joints of the fingers and the thumb we achieve extraordinary quality. Using SmartSpeed we succeed in displaying even very small structures anatomically correct, enabling us to see the extent of possible injuries. Tendons and ligaments appear with higher resolution so we can better see the injury pattern and describe and delimit it.

Our referring physicians are fascinated by the extraordinary quality and high level of detail of the images. Patients are happy that the examination does not take too long. We hear from patients that it took a lot less time than they expected. This is especially important when scanning patients who are very uncomfortable in the MRI environment.”

Improving diagnostic confidence across the board at MRT-Praxis Potsdam
Dr. Schr?ter points out that a more confident diagnosis requires high-quality images with more diagnostic information. “Philips SmartSpeed provided that to us. AI denoises the clinical images without losing any important data, resulting in high-resolution images. It keeps all the information we need and makes the images better.

We can apply SmartSpeed to almost all sequences. That is a big step forward! We use it for example in 3D imaging and in diffusion-weighted imaging, to dramatically reduce scan time or increase image resolution, which is quite useful.

There are small lesions that we would certainly have seen without SmartSpeed, however it would have taken us longer to properly diagnose. In 3D MSK images with extremely high resolution, we uncover the finest anatomical structures and can thus report very detailed findings.”

Helium-free operation helps saving costs
When Dr. Schr?ter initially planned to replace the old MRI system, he learned that safety requirements for the quench system had become so strict that the existing vent pipe could no longer be used and costs for updating it in the heritage-protected building were excessive.

Choosing the Philips Ambition S with its BlueSeal magnet allowed Dr. Schr?ter to avoid the expensive conversion, as this magnet does not require a vent pipe, because the helium is permanently enclosed within the sealed magnet. The seven-liter helium content of the BlueSeal magnet is also significantly lower than the roughly 1,500 liters of other Philips magnets.

“With the BlueSeal magnet we don't need to concern ourselves with helium anymore. Refills are not needed, so there’s no time or cost wasted with that. Sustainability was also an important aspect for me when deciding on BlueSeal. Helium is a resource that is not infinitely available on earth, that's why I think it's good that we have a closed system that only includes seven liters.

As a radiologist I can't see any difference between images from a sealed system and a system that requires regular helium refill. The image quality and the handling are virtually the same.”

Effects of a patient-friendly atmosphere
“In our MRI room we have the Ambient Experience lighting and In-bore experience, which enable us to create a feel-good atmosphere for our patients,” says Dr. Schr?ter. “They feel more comfortable with this experience than in MRI machines without. Our patients love it. It helps many to successfully tolerate the examination. When inside the bore, patients can see the remaining scan time and breath hold guidance on the display. This is very popular. It improves patient engagement and ultimately image quality.

Many patients tell us that if they had known how nice it was in our device, they wouldn't have been afraid of the exam. Patients often say that they will recommend us to others if they ever need an MRI.

Thanks to image quality and a relaxing environment we have been able to scan a higher number of patients. I can emphasize that with the Ambition system, our patient throughput and exam scope have grown.”

Large screen and easy operation
Philips SmartSpeed is available via MR Workspace, the large-screen operator console that empowers the technologist with integrated AI protocol selection.

“The big 27-inch 4K high resolution screen makes a total difference. It shows the large planning images with much higher resolution than we were used to. Anatomic landmarks can be more easily identified, which advances the process. Now it is much easier and faster to plan the new sequences and it’s easier for us to find lesions,” says Dr. Schr?ter.

“MR Workspace is a tool to operate the system more seamlessly. The user interface is designed in a very advanced way. Operation is intuitive. Many actions can be executed via drag and drop. It is really easy to use and self-explanatory. There are small features and tools that improve the work significantly. For example, being able to copy the geometry of one sequence to the next, without having to make any major adjustments.

We also use the new Day manager. During an ongoing examination it allows us to load and adjust the planned examinations for upcoming patients at the same time.”

Powerful GPU rapidly provides images and reconstruction on large screen
Another important part of MR Workspace is the graphics processing unit (GPU), which allows on-the-fly reconstruction times for images acquired with SmartSpeed. “In addition to seeing razor-sharp images on the large 4K monitor, we also have better and faster reconstruction of the images. Using this extremely high resolution, we sometimes have sequences with up to 800 individual images. The GPU then manages to convert them in a matter of seconds into multiplanar reconstructions. Very impressive.”

Staff learning curve
“We’ve received great application training from Phillips”, Dr. Schr?ter says. “My highly motivated technologists were able to recognize the advantages of SmartSpeed in a very short time. Simultaneously they were also getting used to the new MR Workspace, which is completely different from the previous operating console. However, the new workspace is modern and very easy to use. We can simply select SmartSpeed from the menu.

When Compressed SENSE protocols are available, only one click is needed to convert to a SmartSpeed sequence. And we can adjust the denoising levels depending on our needs: strong, medium or weak and achieve the best level for our practice. It makes work easier overall.”

Everybody wins
Dr. Schr?ter believes SmartSpeed is really a step forward. “It is almost incomprehensible that scanning can be so fast. And the images are brilliant. I'm excited. For all of our examinations the scanning time was drastically shortened – particularly the switch to 3D sequences makes a difference. Our practice is now able to use some sequences that were hardly used before because of their long scan time.

SmartSpeed is a real game changer. The decisive factor is that we can now achieve this speed and this high resolution. And I can only say yes to the question on consistency of the picture quality. We can always produce brilliant images with SmartSpeed, so it is not necessary to repeat sequences.

Faster scanning means less possibility for motion artifacts, less rescans and a much better result. We gain more confidence during reporting, so patients are getting a much better diagnosis. Everybody wins.”

Medicine in the 20th centuryThe 20th century produced such a plethora of discoveries and advances that in some ways the ...
25/09/2025

Medicine in the 20th century

The 20th century produced such a plethora of
discoveries and advances that in some ways the
face of medicine changed out of all
recognition. In 1901 in the United Kingdom,
for instance, the life expectancy at birth, a
primary indicator of the effect of health care
on mortality (but also reflecting the state of
health education, housing, and nutrition), was
48 years for males and 51.6 years for females.
After steady increases, by the 1980s the life
expectancy had reached 71.4 years for males
and 77.2 years for females. Other
industrialized countries showed similar
dramatic increases. By the 21st century the
outlook had been so altered that, with the
exception of oft-fatal diseases such as
certain types of cancer, attention was focused
on morbidity rather than mortality, and the
emphasis changed from keeping people alive to
keeping them fit.

The rapid progress of medicine in this era was
reinforced by enormous improvements in
communication between scientists throughout
the world. Through publications, conferences,
and—later—computers and electronic media, they
freely exchanged ideas and reported on their
endeavors. No longer was it common for an
individual to work in isolation. Although
specialization increased, teamwork became the
norm. It consequently has become more
difficult to ascribe medical accomplishments
to particular individuals.

In the first half of the 20th century,
emphasis continued to be placed on combating
infection, and notable landmarks were also
attained in endocrinology, nutrition, and
other areas. In the years following World War
II, insights derived from cell biology altered
basic concepts of the disease process. New
discoveries in biochemistry and physiology
opened the way for more precise diagnostic
tests and more effective therapies, and
spectacular advances in biomedical engineering
enabled the physician and surgeon to probe
into the structures and functions of the body
by noninvasive imaging techniques such as
ultrasound (sonar), computerized axial
tomography (CAT), and nuclear magnetic
resonance (NMR). With each new scientific
development, medical practices of just a few
years earlier became obsolete.

Infectious diseases and chemotherapy
In the 20th century, ongoing research
concentrated on the nature of infectious
diseases and their means of transmission.
Increasing numbers of pathogenic organisms
were discovered and classified. Some, such as
the rickettsias, which cause diseases like
typhus, are smaller than bacteria; some are
larger, such as the protozoans that engender
malaria and other tropical diseases. The
smallest to be identified were the viruses,
producers of many diseases, among them mumps,
measles, German measles, and polio. In 1910
Peyton Rous showed that a virus could also
cause a malignant tumor, a sarcoma in
chickens.

There was still little to be done for the
victims of most infectious organisms beyond
drainage, poultices, and ointments, in the
case of local infections, and rest and
nourishment for severe diseases. The search
for treatments was aimed at both vaccines and
chemical remedies.

Ehrlich and arsphenamine
Germany was well to the forefront in medical
progress. The scientific approach to medicine
had been developed there long before it spread
to other countries, and postgraduates flocked
to German medical schools from all over the
world. The opening decade of the 20th century
has been well described as the golden age of
German medicine. Outstanding among its leaders
was Paul Ehrlich.

innovative proposals earn funding to change residency trainingProjects aiming to better prepare residents for entry to p...
11/09/2025

innovative proposals earn funding to change
residency training

Projects aiming to better prepare residents
for entry to practice, address health
inequities and improve residency selection
through preference signaling will move forward
with funding from the AMA.

The three proposals each will earn $20,000 in
funding as winners of the AMA GME Innovation
Challenge after being selected as the top
project proposals from a group of 25 at the
recent AMA GME Innovations Summit.

A “Shark Tank”-style competition, the GME
Innovation Challenge received more than 125
submissions, 25 of which were presented at the
virtual meeting this month. Five finalists
advanced to a Q&A session with leaders in
residency education on the event’s final day,
with the three winning proposals being
announced at the conference’s conclusion.

“The ideas that were selected reflect the
interest people have in addressing those
specific areas of graduate medical education—
competency-based medical education and
preparation for independent practice, health
equity and understanding the communities we
serve, addressing an increase in applications
to residency programs and the anxiety that
applicants may feel because of it,” said John
Andrews, MD, the AMA’s vice president for GME
innovations.

Improving health outcomes locally
A project proposal submitted by Anita
Blanchard, MD, professor of obstetrics and
gynecology and associate dean for graduate
medical education at the University of
Chicago, aims to address heath inequities in
the community surrounding the health system.

People who live in the South Side neighborhood
surrounding the University of Chicago have
life expectancies of up to 20 years fewer than
residents in other areas of the city. Dr.
Blanchard proposed a plan that would foster
resident physician connections with the
surrounding community while integrating
community needs assessment into the GME
curriculum.

The proposal calls for all first-year
residents to learn foundational skills in
implicit bias, cultural humility and community
awareness. Advanced residents will serve as
community champion liaisons to foster
meaningful, sustainable partnerships between
their GME programs and UChicago Urban Heath
Initiative, an organization that fosters
robust urban revitalization efforts.

Find out why this Black intern, a grandfather,
worked many years as mechanic.

Finding the perfect match
Residency applications are on the rise,
complicating matters for residency programs
and the medical students applying. A proposal
submitted by Jesse Burk-Rafel, MD, an
assistant professor of medicine at New York
University Grossman School of Medicine, calls
for moving to a system that allows applicants
to convey the seriousness of their interest to
select number of residency programs.

Applicants would get a limited number of
“roses”—a nod to a famed dating show—to give
to programs at the time of submitting their
residency application to signal their genuine
interest in that program. “Roses” would be
limited to a small number, perhaps five, and
programs would know by receiving a rose that
the applicant had used a scarce resource to
indicate their sincere enthusiasm.

Learn how ob-gyns got help to redesign the
residency application process.

Last step before independent practice
A proposal submitted by Rebecca Jaffe, MD, an
associate professor in the hospital medicine
division at Thomas Jefferson University, looks
to add a “pre-attendingship” to the end of
residency training.

The proposal would allow graduating residents
a final opportunity to integrate knowledge
across competencies, encounter attending-level
health systems science challenges in a
controlled environment, and demonstrate
readiness for practice before graduation.

The initiative calls for pre-attendings to go
through many of the tasks in their future,
such as scheduling room coverage; maximizing
safety, quality and productivity; billing for
services; and interacting with collaborating
health professionals. Supervision would occur
at the “oversight” level, including weekly
meetings with faculty to incorporate feedback,
review performance metrics, and set goals for
self-directed learning.

Changing GME
With more than 100 presentations over three
days, the GME Innovations Summit was an
extension of the AMA’s ongoing work to reshape
GME. The AMA Reimagining Residency initiative
has awarded more than $15 million in grants to
institutions that will transform residency
training to meet the workforce needs of
America’s current and future health care
system.

Medical innovation takes center stage in state legislaturesRecently, PhRMA had the opportunity to partner with the Natio...
28/08/2025

Medical innovation takes center stage in state legislatures

Recently, PhRMA had the opportunity to partner with the National Conference of State Legislatures (NCSL) for a panel discussion at their 2025 Legislative Summit in Boston, Massachusetts. The panel discussion centered around groundbreaking U.S. biopharmaceutical innovations, the positive impact for patients globally, and the policies that can nurture and protect them for generations to come.

Nearly all innovative, impactful medicines have one thing in common: They start and end in the states.

States play a critical role in providing an environment where academic institutions, research centers and private companies collaborate. Clinical trials also take place in communities across the country, giving patients access to promising treatments. And, once approved, medicines are delivered back through local doctors, hospitals and pharmacists.

Innovation is deeply human. During the panel, we heard stories about:

HIV/AIDS: How grassroots care and community models can help bridge trust and connect patients in marginalized communities with innovative treatments.
Rare disease & NICU care: One panelist shared how access to cutting-edge clinical trials in his home state of Massachusetts saved his premature twins, showing how location and access can mean the difference between life and loss.
Cancer & beyond: New medicines contributed to 1.3 million fewer cancer deaths (2000–2016). Cardiovascular and mental health therapies are reshaping outcomes for patients nationwide.
Even when a drug doesn’t make it to approval, the search itself strengthens local and state economies:

The biopharmaceutical sector supports more than 90,000 jobs in Massachusetts.
North Carolina hosts nearly 800 life sciences companies employing 70,000 people.
Across the U.S., the biopharmaceutical sector drives $1.6 trillion in economic output with facilities in 48 states.
Bottom line: With the right political environment, states are the perfect place to host collaboration, bring promising treatments to patients through clinical trials, and act as the hub for significant economic and workforce benefits in the process.

AI-enhanced echocardiography improves early detection of amyloid buildup in the heartAn artificial intelligence (AI) mod...
21/08/2025

AI-enhanced echocardiography improves early
detection of amyloid buildup in the heart

An artificial intelligence (AI) model
developed by Mayo Clinic and Ultromics, Ltd.,
an AI echocardiography company based in
Oxford, England, is highly accurate in
screening for cardiac amyloidosis, a rare and
progressive type of heart failure, according
to a new study. The model is the first and
only AI tool of its kind.

Researchers from Mayo Clinic and Ultromics,
with investigators at the University of
Chicago Medicine and collaborators around the
world, validated and tested the model on a
large and multiethnic patient population and
compared its abilities to other diagnostic
methods for cardiac amyloidosis.

Their findings, published in the European
Heart Journal, show that the AI model was
highly accurate, with 85% sensitivity
(correctly identifying those with the disease)
and 93% specificity (correctly identifying
those without the disease). Using a single
echocardiography videoclip, the model was
effective across all major types of cardiac
amyloidosis and distinguished it from other
conditions with similar characteristics.

Cardiac amyloidosis is a life-threatening
condition where an abnormal protein, called
amyloid, builds up in the heart, causing it to
stiffen and not work properly. It is often
missed because the symptoms and imaging
features can be similar to other heart
conditions. However, early diagnosis is
crucial because new drug therapies are now
available that can slow or stop the disease's
progression.

This work builds on the previous experience of
Mayo Clinic and Ultromics in developing an AI
echocardiography model to detect heart failure
with preserved ejection fraction (HFpEF),
which received Food and Drug Administration
(FDA) clearance in 2022. HFpEF is a common
type of heart failure, associated with high
morbidity and mortality, but can be
challenging to diagnose. An estimated 15% of
patients with HFpEF have cardiac amyloidosis.

"This AI model is a breakthrough tool that can
help us identify patients earlier so they can
receive the treatment they need," says
Patricia Pellikka, M.D., a cardiologist at
Mayo Clinic and past director of the Mayo
Clinic Echocardiography Lab in Rochester. "We
found that AI performed better than
traditional clinical and transthoracic echo-
based screening methods, providing clinicians
with stronger insights on which to base
decisions for further confirmation tests. New
treatments are available for cardiac
amyloidosis but are most effective if
administered early in the course of the
disease." Dr. Pellikka is senior author of the
study.

The amyloid AI model is FDA-cleared and is
currently being used at multiple centers in
the U.S. Dr. Pellikka says she looks forward
to applying this technology in the clinical
practice at Mayo Clinic.

This study was partially supported by a grant
from Ultromics and Dr. Pellikka is supported
as the Betty Knight Scripps-George M. Gura,
Jr., M.D. Professor of Cardiovascular Diseases
Clinical Research at Mayo Clinic. Mayo Clinic
has a financial interest in this technology
and will use any revenue it receives to
support its not-for-profit mission in patient
care, education and research.

BP Meds Should Begin Promptly, New ACC/AHA Guidelines SayThe target blood pressure level for adults remains below 130/80...
15/08/2025

BP Meds Should Begin Promptly, New ACC/AHA
Guidelines Say

The target blood pressure level for adults
remains below 130/80 mm Hg, but drug therapy
should be initiated sooner, according to new
guidelines published Thursday by the American
Heart Association (AHA) and American College
of Cardiology (ACC). Eleven other medical
organizations endorsed the new guidelines,
which replace those issued in 2017.

“We’re trying to get started earlier in the
process of preventing cardiovascular disease,”
said Daniel W. Jones, MD, dean and professor
emeritus of the University of Mississippi
School of Medicine in Jackson, who chaired the
guidelines committee.

Almost half of American adults have
hypertension, according to the AHA.

In the previous guidelines, a systolic blood
pressure of 140 mm Hg or higher or a diastolic
blood pressure of 90 mm Hg and above were the
thresholds to initiate medications for primary
prevention. The new guidelines recommend drug
therapy if blood pressure remains at or above
130/80 mm Hg after 3-6 months of lifestyle
changes such as eating a healthier diet.

Antihypertensive medications should begin
right away in adults with hypertension with
diabetes or chronic kidney disease or an
elevated 10-year risk of cardiovascular
disease, per the guidelines. The
cardiovascular disease risk calculation should
be based on the PREVENT risk calculator
published by the AHA in 2023.

While the target blood pressure goal is below
130/80 mm Hg, Jones said clinicians should
encourage patients to achieve readings lower
than 120/80 mm Hg when possible. The AHA and
ACC continue to recommend the heart-friendly
DASH diet that emphasizes fruits, vegetables,
fat free or low fat dairy products, fish,
poultry, beans, and nuts.

Recent Research Spurred Review
The new guidelines incorporate research about
controlling high blood pressure from 2015 to
2024. One new focus this time is the link
between high blood pressure and dementia.

“Lowering blood pressure in an intensive way
reduces the risk of dementia,” Jones said.

In addition to medication as appropriate,
reducing salt intake, staying physically
active, lowering weight, and managing stress
can all blunt the risk for dementia, the
authors of the guidelines found. Doing so
would also reduce risks for heart attack,
stroke, heart failure, and kidney disease,
they noted.

The guidelines also call for screening for
primary aldosteronism in patients with
resistant hypertension, regardless of whether
they have hypokalemia.

The document also makes two “important”
changes to laboratory testing: testing the
ratio of urine albumin and creatinine for all
patients with high blood pressure — which
formerly was considered an optional test — and
developing tailored approaches to medication
for high blood pressure.

The new guidelines suggest patients discuss
renal denervation with their clinicians as a
way to reduce the need for medication, but the
document falls short of recommending the
procedure.

The 2017 guidelines advised no more than 2300
mg of sodium intake per day; now the
recommendation is to cap sodium at 1500 mg per
day. And people who want to prevent or manage
hypertension should not drink alcohol at all,
according to the new guidelines.

Men who drink should limit their intake to two
alcoholic beverages per day; women to one.
That’s a daily limit, not a rolling average,
Jones stressed. Saving drinks for the weekend
is not a thing when blood pressure management
is concerned.

“Losing weight lowers blood pressure,” added
Jones, who encouraged patients to consider
using a GLP-1 inhibitor when clinically
appropriate. Women who are pregnant or
expecting to become pregnant should consider
using low-dose aspirin to prevent risk of
preeclampsia, the guidelines state.

“High blood pressure during pregnancy predicts
high blood pressure for the rest of your
life,” Jones said. Given this reality the new
guidelines spend more time on pregnancy than
the previous version.

Address

UK Address: PLUM TREE HOUSE/OLD VICARAGE Lane SWINDON/UNITED KINGDOM/SN3 4SH : Dubai Address:Office No. 2108, Jumeirah Bay Tower/Dubai/
Dubai

Opening Hours

Monday 08:00 - 18:00
Tuesday 08:00 - 18:00
Wednesday 08:00 - 18:00
Thursday 08:00 - 18:00
Sunday 08:00 - 18:00

Alerts

Be the first to know and let us send you an email when Evorin pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Evorin pharma:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category